A Review on Novel Antiretroviral Drug Therapy Approved by FDA Since 2019
with drug class and also include recently approved drugs and their combination therapy by FDA
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
with drug class and also include recently approved drugs and their combination therapy by FDA
Food and Drug Administration (FDA) defines a biomarker as “a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure ... lack of…
Design: We studied all renal toxicities reported by selected novel targeted therapies to the FDA Adverse Event Reporting System (FAERS) 3rd quarter of 2011 to 2nd quarter
guidance issued by European Medicines Agency (EMA) have recently undergone revisions and the FDA has issued number of revised guidelines for Quality and Scientific Considerations as well as updated Questions ... Answers…
attempt to encourage innovative drug development, the FDA hasdeveloped four programs to expedite the drug approval process for innovative or potential high-impact therapies. These four approaches include FastTrack…
regulation for a targeted GxP operation is often at regulatory agencies discretion. What will FDA really enforce with their limited resource and where they focus on? Facing the challenges from ... time. This…
crucial components of numerous biologically vital substances and are prominent scaffolds in US-FDA-approved drugs and energetic materials, underscoring their significant role in enhancing human life quality. This review…
rigorous, multi phase journey governed by the U.S. Food and Drug Administration (FDA). For pharmaceutical innovators, understanding this process is not just a regulatory necessity—it’s a strategic imperative ... From…
launch or keep a medical device on the US market, FDA pre-approval or continued approval is required. After product approval, the FDA routinely conducts surveillance inspections of medical device ... medical device CAPA…
through the evaluation of warning letters issued by the US Food and Drug Administration (FDA) between 2013 and 2022. The results of this study indicate that despite the medical device
because p53 mutations are specific to cancer. The mechanisms of action and activities of FDA-approved and clinically available drugs that target p53 mutations to stop the progression of cancer
Development of new anticancer medications is essential for both patient care and
This review is an update of dengue recent outbreaks and newer US FDA approved drugs based on worldwide data. Dengue is a self-limited, universal viral infection transmitted among person
because p53 mutations are specific to cancer. The mechanisms of action and activities of FDA-approved and clinically available drugs that target p53 mutations to stop the progression of cancer
Staphylococcus aureus is an opportunistic pathogen that causes wide range of nosocomial
For authors and organisers
Find the right journal for your paper and submit your manuscript.